Skip to main content
CodeRx
↑↓ move↵ open CodeRx
Loading…
S2107 — Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment · CodeRx